or Try an Advanced Search...

    Technical Analysis for CUE - Cue Biopharma, Inc.

    Grade Last Price % Change Price Change
    D 1.64 5.81% 0.09
    CUE closed up 5.81 percent on Wednesday, May 15, 2024, on 89 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
    Earnings due: Jun 5
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CUE trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 0.00%
    Lizard Bullish Bullish Day Trade Setup 0.00%
    Doji - Bullish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    20 DMA Resistance Bearish 5.81%
    MACD Bearish Centerline Cross Bearish 5.81%
    MACD Bearish Signal Line Cross Bearish 5.81%
    Wide Bands Range Expansion 5.81%
    Down 3 Days in a Row Weakness 5.81%
    Older End-of-Day Signals for CUE ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed about 17 hours ago
    Gap Up Partially Closed about 17 hours ago
    60 Minute Opening Range Breakdown about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    Down 1% about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CUE Chart by TradingView
    Basic chart:

    Profile

    Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Immune System Pharmacy Medication Autoimmunity Specialty Drugs Autoimmune Disorders Immune Disorders

    Is CUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 11 Cue Biopharma First Quarter 2024 Earnings: Beats Expectations
    May 9 Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M
    May 9 Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 8 Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
    Apr 24 Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Apr 9 Q4 2023 Cue Biopharma Inc Earnings Call
    Apr 9 Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...
    Apr 9 Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript
    Apr 8 Cue Biopharma GAAP EPS of -$0.28 misses by $0.01
    Apr 8 Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
    See more CUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.89
    52 Week Low 1.3027
    Average Volume 297,732
    200-Day Moving Average 2.37
    50-Day Moving Average 1.81
    20-Day Moving Average 1.72
    10-Day Moving Average 1.87
    Average True Range 0.21
    RSI (14) 45.05
    ADX 21.71
    +DI 17.37
    -DI 22.89
    Chandelier Exit (Long, 3 ATRs) 1.64
    Chandelier Exit (Short, 3 ATRs) 1.92
    Upper Bollinger Bands 2.21
    Lower Bollinger Band 1.22
    Percent B (%b) 0.42
    BandWidth 57.93
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0151
    Fundamentals Value
    Market Cap 74 Million
    Num Shares 45.1 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -1.37
    Price-to-Sales 27.76
    Price-to-Book 2.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.86
    Resistance 3 (R3) 1.84 1.75 1.82
    Resistance 2 (R2) 1.75 1.70 1.76 1.81
    Resistance 1 (R1) 1.70 1.66 1.65 1.71 1.80
    Pivot Point 1.61 1.61 1.59 1.62 1.61
    Support 1 (S1) 1.55 1.55 1.51 1.57 1.48
    Support 2 (S2) 1.46 1.52 1.47 1.47
    Support 3 (S3) 1.41 1.46 1.46
    Support 4 (S4) 1.42